Abstract : Evidence‐Based Answer : Subcutaneous allergen immunotherapy effectively reduces symptoms and decreases rescue medication usage for patients with seasonal allergic rhinitis. Sublingual allergen immunotherapy has similar results in seasonal and perennial allergic rhinitis (SOR: A, meta‐analyses of RCTs).